Matches in SemOpenAlex for { <https://semopenalex.org/work/W3037680403> ?p ?o ?g. }
- W3037680403 endingPage "112461" @default.
- W3037680403 startingPage "112461" @default.
- W3037680403 abstract "Abstract To develop inhibitors blocking VEGFR2 and the Raf/MEK/ERK mitogen-activated protein kinase signaling pathway new compounds based on sorafenib were designed, synthesized and biologically evaluated. Using de novo design method, a library of new ligands was generated and expanded. Considering in silico binding affinity towards VEGFR2, synthetic feasibility, and drug-likeness property, some of the designed ligands were selected for synthesis and screening for their in vitro antiproliferative activities against two cancer cell lines (HT-29 and A549). Four compounds (13a, 14a, 14l and 15b) exhibited stronger antiproliferative activity (with IC50 values of 13.27, 6.62, 12.74, 3.38 μM, respectively) against HT-29 cells compared to that of the positive reference drug sorafenib (IC50 = 17.28 μM). Notably, compound 15b demonstrated the highest activity, and in particular, it induced HT-29 apoptosis, increased intracellular reactive oxygen species level, arrested cell cycle at G0/G1 phase, and influenced the expression of apoptosis- and cell cycle-related proteins. 15b compound can effectively block the Raf/MEK/ERK pathway and inhibit VEGFR2 phosphorylation. Molecular docking revealed that 15b can bind well to the active site of VEGFR2 receptor. Collectively, 15b may be considered as a promising compound amenable for further investigation for the development of new anticancer agents." @default.
- W3037680403 created "2020-07-02" @default.
- W3037680403 creator A5000390912 @default.
- W3037680403 creator A5008095776 @default.
- W3037680403 creator A5009670303 @default.
- W3037680403 creator A5014560113 @default.
- W3037680403 creator A5040891071 @default.
- W3037680403 date "2020-09-01" @default.
- W3037680403 modified "2023-10-18" @default.
- W3037680403 title "Synthesis and biological evaluation of diaryl urea derivatives designed as potential anticarcinoma agents using de novo structure-based lead optimization approach" @default.
- W3037680403 cites W1539571840 @default.
- W3037680403 cites W1885676901 @default.
- W3037680403 cites W1936616268 @default.
- W3037680403 cites W1972752540 @default.
- W3037680403 cites W1976096573 @default.
- W3037680403 cites W1977467384 @default.
- W3037680403 cites W1978009405 @default.
- W3037680403 cites W1978222579 @default.
- W3037680403 cites W1980321528 @default.
- W3037680403 cites W1982915980 @default.
- W3037680403 cites W2003076573 @default.
- W3037680403 cites W2005671628 @default.
- W3037680403 cites W2011505858 @default.
- W3037680403 cites W2028238072 @default.
- W3037680403 cites W2039350725 @default.
- W3037680403 cites W2041686943 @default.
- W3037680403 cites W2049210214 @default.
- W3037680403 cites W2051259556 @default.
- W3037680403 cites W2052907531 @default.
- W3037680403 cites W2053599004 @default.
- W3037680403 cites W2061345986 @default.
- W3037680403 cites W2062854977 @default.
- W3037680403 cites W2063544208 @default.
- W3037680403 cites W2073001877 @default.
- W3037680403 cites W2078666944 @default.
- W3037680403 cites W2079991727 @default.
- W3037680403 cites W2085313140 @default.
- W3037680403 cites W2103231497 @default.
- W3037680403 cites W2105649494 @default.
- W3037680403 cites W2106932520 @default.
- W3037680403 cites W2113582953 @default.
- W3037680403 cites W2113788015 @default.
- W3037680403 cites W2119752391 @default.
- W3037680403 cites W2125275331 @default.
- W3037680403 cites W2135086805 @default.
- W3037680403 cites W2135732933 @default.
- W3037680403 cites W2294932319 @default.
- W3037680403 cites W2522561466 @default.
- W3037680403 cites W2617775634 @default.
- W3037680403 cites W2752324783 @default.
- W3037680403 cites W2793323124 @default.
- W3037680403 cites W2905553561 @default.
- W3037680403 cites W2949927825 @default.
- W3037680403 cites W2968536537 @default.
- W3037680403 doi "https://doi.org/10.1016/j.ejmech.2020.112461" @default.
- W3037680403 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32663641" @default.
- W3037680403 hasPublicationYear "2020" @default.
- W3037680403 type Work @default.
- W3037680403 sameAs 3037680403 @default.
- W3037680403 citedByCount "17" @default.
- W3037680403 countsByYear W30376804032021 @default.
- W3037680403 countsByYear W30376804032022 @default.
- W3037680403 countsByYear W30376804032023 @default.
- W3037680403 crossrefType "journal-article" @default.
- W3037680403 hasAuthorship W3037680403A5000390912 @default.
- W3037680403 hasAuthorship W3037680403A5008095776 @default.
- W3037680403 hasAuthorship W3037680403A5009670303 @default.
- W3037680403 hasAuthorship W3037680403A5014560113 @default.
- W3037680403 hasAuthorship W3037680403A5040891071 @default.
- W3037680403 hasConcept C114373084 @default.
- W3037680403 hasConcept C114793014 @default.
- W3037680403 hasConcept C127313418 @default.
- W3037680403 hasConcept C127413603 @default.
- W3037680403 hasConcept C178790620 @default.
- W3037680403 hasConcept C183696295 @default.
- W3037680403 hasConcept C185592680 @default.
- W3037680403 hasConcept C202751555 @default.
- W3037680403 hasConcept C21951064 @default.
- W3037680403 hasConcept C2777093003 @default.
- W3037680403 hasConcept C2777752112 @default.
- W3037680403 hasConcept C2780365088 @default.
- W3037680403 hasConcept C55493867 @default.
- W3037680403 hasConcept C71240020 @default.
- W3037680403 hasConceptScore W3037680403C114373084 @default.
- W3037680403 hasConceptScore W3037680403C114793014 @default.
- W3037680403 hasConceptScore W3037680403C127313418 @default.
- W3037680403 hasConceptScore W3037680403C127413603 @default.
- W3037680403 hasConceptScore W3037680403C178790620 @default.
- W3037680403 hasConceptScore W3037680403C183696295 @default.
- W3037680403 hasConceptScore W3037680403C185592680 @default.
- W3037680403 hasConceptScore W3037680403C202751555 @default.
- W3037680403 hasConceptScore W3037680403C21951064 @default.
- W3037680403 hasConceptScore W3037680403C2777093003 @default.
- W3037680403 hasConceptScore W3037680403C2777752112 @default.
- W3037680403 hasConceptScore W3037680403C2780365088 @default.
- W3037680403 hasConceptScore W3037680403C55493867 @default.
- W3037680403 hasConceptScore W3037680403C71240020 @default.
- W3037680403 hasFunder F4320322587 @default.